This process takes 12 hours after ingestion, creating a slower onset of action compared to injection
What the Clinical Evidence Shows While large-scale randomized controlled trials specifically measuring testosterone as a primary endpoint in tirzepatide users are still emerging, the available evidence is encouraging: The SURMOUNT trials demonstrated average weight losses of 15-22.5% of body weight, a degree of fat reduction strongly associated with testosterone recovery in men with obesity-related hypogonadism (Jastreboff et al., 2022, NEJM )
Reports of adverse effects have included nausea, vomiting, stomach pain, fainting, headache, dehydration, gallstones, and inflammation of the pancreas
Taking glutathione not only improves skin health but also helps the body remove pollutants
Eng presented a modest poster summarizing his findings